Identity
- Security key
- 22164
- Ticker
- STVN
- Type
- CS — Common Stock
- Exchange
- New York Stock Exchange(XNYS)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-07-16
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- STVN
Detail
Enriched 2026-08-14 20:47
- Market cap
- $5,803,931,261.25
- Shares outstanding (class)
- 302,842,536
- Shares outstanding (weighted)
- 273,126,177
- SIC
- —
- Employees
- 5,795
- Location
- —
- Homepage
- https://www.stevanatogroup.com
- Description
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.